Health Insurance (Accredited Pathology Laboratories — Approval) Amendment Principles 2013 (No.1)
Health Insurance Act 1973
I, Richard Bartlett, delegate of the Minister for Health, make these Principles under subsection 23DNA (1) of the Health Insurance Act 1973.
1 Name of Principles
These Principles are the Health Insurance (Accredited Pathology Laboratories – Approval) Amendment Principles 2013 (No.1).
2 Commencement
These Principles commence on 1 December 2013.
3 Authority
These Principles are made under subsection 23DNA(1) of the Health Insurance Act 1973.
4 Schedule
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1 Amendment
Health Insurance (Accredited Pathology Laboratories ― Approval) Principles 2002
substitute
Schedule 1 Accreditation materials
(section 5)
Item | Material | Publication Year |
1 | Requirements for Medical Pathology Services (First Edition 2013) | 2013 |
2 | Requirements for Procedures Related to the Collection, Processing, Storage and Issue of Human Haemopoietic Progenitor Cells (Fourth Edition 2013) | 2013 |
3 | Requirement for the Facilities and Operation of Mortuaries (Third Edition 2013) | 2013 |
4 | Requirements for Enrolment and Participation in External Quality Assessment (Fifth Edition 2013) | 2013 |
5 | Guidelines for Approved Pathology Collection Centres (Requirements for Medical Pathology Specimen Collection) (Third Edition 2013) | 2013 |
6 | Requirements for the Performance of Anatomical Pathology Cut-Up (Fourth Edition 2013) | 2013 |
7 | Guidelines for the use of Liquid Based Collection Systems and Semi‑Automated Screening Devices in the Practice of Gynaecological (Cervical) Cytology | 2006 |
8 | Requirements for Medical Testing of Human Nucleic Acids (Second Edition 2013) | 2013 |
9 | Performance Measures for Australian Laboratories Reporting Cervical Cytology | 2006 |
10 | Requirements for Gynaecological (Cervical) Cytology | 2006 |
11 | Requirements for the Supervision of Pathology Laboratories | 2007 |
12 | Requirements for Laboratory Testing for Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV) (Third Edition 2013) | 2013 |
13 | Requirements for Medical Testing of Microbial Nucleic Acids (Second Edition 2013) | 2013 |
14 | Requirements for Cytogenetic Testing (Second Edition 2013) | 2013 |
15 | Requirements for Information Communication (Third Edition 2013) | 2013 |
16 | Requirements for the Packaging and Transport of Pathology Specimens and Associated Materials (Third Edition 2013) | 2013 |
17 | Requirements for the Development and Use of In‑house In Vitro Diagnostic Devices (IVDs) | 2007 |
18 | Requirements for the Estimation of Measurement Uncertainty | 2007 |
19 | Requirements for the Retention of Laboratory Records and Diagnostic Material (Sixth Edition 2013) | 2013 |
20 | Requirements for Transfusion Laboratory Practice (Second Edition 2013) | 2013 |
Note The documents mentioned in Part 1 are available on the Internet — see http://www.health.gov.au/npaac.
Part 2 Supplementary materials
Note The document mentioned in item 1 is available from the National Association of Testing Authorities – see http://www.nata.asn.au.